African trypanosomiasis or sleeping sickness is a tropical disease spread by the bite of an infected tsetse fly. It can be fatal if not treated.
TDR is completing studies of the efficacy and safety of a shortened pentamidine treatment for stage 1 of the disease (3 days instead of 7) and nifurtimox-eflornithine combination treatment for stage 2 of the disease.
- New series on helminth infections R&D agenda
- Dengue control support through eco-bio-social approach
- A call for closer ties to communities
- Pipeline grows for neglected diseases research and development (R&D)
- VL elimination by 2015 on track with new research
- Onchocerciasis can be eliminated with ivermectin
- VL rapid diagnostics may be inadequate in Brazil and East Africa